• Obtained TFDA GDP certification

2017

• Manufacturing plant obtained Japan PMDA registration
• Manufacturing plant II obtained PIC/S GMP certification
• Stock officially issued

2016

• First generic drug approved in Taiwan for primary hypercholesterolemia- Agitin Tablets 10/20mg
• GS1 serialization set up in manufacturing plant, cooperating with Japanese well-knowed manufacturer as an Asian Packaging Center

2015

• Established Oral Controlled Release Dosage Form to improve drug release rate, and use this technology into urinary system medication. First ER form generic drug approved in Taiwan for benign prostatic hyperplasia- Tamsulosin HCl 0.4mg
• First generic drug, that was improved through manufacturing process and patient taking method, approved in Taiwan for hyperphosphatemia of hemodialysis patient- Sevelamer Carbonate 800mg/Sachet
• First generic drug approved in Taiwan for epilepsy, neuropathic pain and GAD- Pregabalin 75mg

2014

• R&D center moved to Hsinchu and expanded development equipment
• First bioequivalent drug approved in Taiwan for secondary hyperparathyroidism- Cinacalcet

2013

• First bioequivalent new combination drug approved in Taiwan for diabetes- Repaglinide+Metformine
• Overcoming patent threshold, bioequivalent drug approved in Taiwan for hypertension- Valsartan+Amlodipine 
• Acquired manufacturing plant (AUPA), PIC/S GMP certificated

2012

• 13 drugs approved in 2012, included 5 bioequivalent drugs, new API drug, and products that overcome patent threshold
• First bioequivalent new API drug approved in Taiwan for insomnia -Eszopiclone
• Overcoming patent threshold, bioequivalent drug approved in Taiwan for hepatitis B- Entecavir
• Overcoming patent threshold, first new dosage form combination drug approved in Taiwan for hypertension- Valsartan+HCTZ
• First bioequivalent drug approved in Taiwan for hypotension- Amezinium

2011

• First bioequivalent drug approved in Taiwan for ADHD- Atomoxetine 25mg

2010

• First new dosage form drug approved in Taiwan for NSAID -Lornoxicam 4、8mg
• First bioequivalent drug approved in Taiwan of antibiotic medication- Azithromycin Oral Suspension
• Overcoming patent threshold, first drug approved in Taiwan for hyperphosphatemia of hemodialysis patient- Sevelamer HCl 400mg

2009

• First new strength and new indication drug approved in Taiwan for pediatric dose for allergic rhinitis- Desloratadine 2.5mg
• First new strength drug approved in Taiwan for diabetes mellitus- Glimepiride 4mg

2008

• 18 drugs approved in 2008, included 3 bioequivalent drugs
• First bioequivalent drug approved in Taiwan for schizophrenia- Amisulpride 400mg
• First bioequivalent drug approved in Taiwan for schizophrenia -Quetiapine 25mg
• First bioequivalent drug approved in Taiwan of antibiotic medication -Levofloxacin 500mg

2007

• Established Orally Instant Disintegrating Formation Development Platform.
• 14 drugs approved in 2007, included 3 bioequivalent drugs
• First bioequivalent drug approved in Taiwan for hypertension- Losartan Potassium+Hydrochlorothiazide
• First bioequivalent drug approved in Taiwan for hight blood cholesterol -Atorvastatin

2006

• First bioequivalent drug approved in Taiwan for asthma- Montelukast
• 22 drugs approved in 2006, included 8 bioequivalent drugs
• Expanded development equipment for Metformin HCl 1000mg, established Pellets Control Release Dosage Development Platform
• Established Film Coated Control Release Dosage Development Platform

2005

• First bioequivalent drug approved for diabetes mellitus-ROXITON F.C. TABLETS 60MG
• 11 drugs approved in 2005, included 3 bioequivalent drugs
• Lab moved to Hsinchu and expanded development equipment
• Products commissioned by US pharmaceutical company passed FDA's BE test
• Established HPMC matrix type Oral Extend Release Dosage Development Platform
• Technology tranfer to well-knowed pharmaceutical company in Malaysia

2004

• First self-developped drug approved of gastric & intestine medication-ACIDEN TABLET
• Contract developing project consigned by US well-knowed pharmaceutical company

2003

• Anxo Pharmaceutical Co., Ltd. was founded